Gastric cancer surgery in cirrhotic patients: Result of gastrectomy with D2 lymph node dissection

被引:47
作者
Lee, Jun Ho [2 ]
Kim, Junuk [1 ]
Cheong, Jae Ho [1 ,3 ]
Hyung, Woo Jin [1 ,3 ,4 ]
Choi, Seung Ho [1 ]
Noh, Sung Hoon [1 ,3 ,4 ]
机构
[1] Yonsei Univ, Dept Surg, Coll Med, Seoul, South Korea
[2] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea
[3] Yonsei Univ, Canc Metastasis Res Ctr, Coll Med, Seoul, South Korea
[4] Yonsei Univ, Brain Korea Project Med Sci 21, Coll Med, Seoul, South Korea
关键词
Gastric cancer; Liver cirrhosis; D2 lymph node dissection; Morbidity; Mortality;
D O I
10.3748/wjg.v11.i30.4623
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To explore the feasibility of performing gastrectomy with D2 lymphadenectomy in gastric cancer patients with liver cirrhosis. METHODS: A total of 7 178 patients were admitted with a diagnosis of liver cirrhosis from January 1993 to December 2003. We reviewed the records of 142 patients who were diagnosed with liver cirrhosis and gastric adenocarcinoma during the same period. Gastrectomy with D2 lymph node dissection for carcinoma of the stomach was performed in 94 patients with histologically proven hepatic cirrhosis. RESULTS: All but 12 patients were classified as Child's class A. Only 35 patients (37.2%) were diagnosed with cirrhosis before operation. Seventy-three patients underwent a subtotal gastrectomy (77.7%) and 21 patients (22.3%) underwent a total gastrectomy, each with D2 or more lymph node dissection. Two patients (3.8%) who had prophylactic intra-operative drain placement, died of postoperative complications from hepatorenal failure with intractable ascites. Thirty-seven patients (39.4%) experienced postoperative complications. The extent of gastric resection did not influence the morbidity whereas serum aspartate aminotransferase level (P = 0.011) and transfusion did (P = 0.008). The most common postoperative complication was ascites (13.9%) followed by wound infection (10.6%). CONCLUSION: We concluded that the presence of compensated cirrhosis, i.e. Child class A, is not a contraindication against gastrectomy with D2 or more lymph node dissection, when curative resection for gastric cancer is possible. Hepatic reserve and meticulous hemostasis are the likely determinants of operative prognosis. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
引用
收藏
页码:4623 / 4627
页数:5
相关论文
共 18 条
[1]
Colorectal adenocarcinoma in cirrhotic patients [J].
Gervaz, P ;
Pak-art, R ;
Nivatvongs, S ;
Wolff, BG ;
Larson, D ;
Ringel, S .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 196 (06) :874-879
[2]
Surgery for gastric cancer in patients with cirrhosis [J].
Isozaki, H ;
Okajima, K ;
Ichinona, T ;
Fujii, K ;
Nomura, E ;
Izumi, N .
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1997, 27 (01) :17-21
[3]
Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy [J].
Karl, RC ;
Schreiber, R ;
Boulware, D ;
Baker, S ;
Coppola, D .
ANNALS OF SURGERY, 2000, 231 (05) :635-641
[4]
The prognosis of liver cirrhosis in recent years in Korea [J].
Kim, YS ;
Um, SH ;
Lee, JW ;
Park, DK ;
Kim, YS ;
Jin, YT ;
Chun, HJ ;
Lee, HS ;
Lee, SW ;
Choi, JH ;
Kim, CD ;
Hyun, IH .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2003, 18 (06) :833-841
[5]
Intractable ascites following surgery for gastric carcinoma [J].
Kumagai, K .
DIGESTIVE SURGERY, 1998, 15 (03) :236-240
[6]
Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases [J].
Liu, CL ;
Fan, ST ;
Lo, CM ;
Wong, Y ;
Ng, IOL ;
Lam, CM ;
Poon, RTP ;
Wong, J .
ANNALS OF SURGERY, 2004, 239 (02) :194-201
[7]
Abdominal operations in patients with cirrhosis: Still a major surgical challenge [J].
Mansour, A ;
Watson, W ;
Shayani, V ;
Pickleman, J .
SURGERY, 1997, 122 (04) :730-735
[8]
NISHI M, 1995, JAPANESE CLASSIFICAT, P6
[9]
Gastric cancer surgery: Morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy - Japan Clinical Oncology Group Study 9501 [J].
Sano, T ;
Sasako, M ;
Yamamoto, S ;
Nashimoto, A ;
Kurita, A ;
Hiratsuka, M ;
Tsujinaka, T ;
Kinoshita, T ;
Arai, K ;
Yamamura, Y ;
Okajima, K .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :2767-2773
[10]
Shin Hai Rim, 2002, Cancer Res Treat, V34, P405, DOI 10.4143/crt.2002.34.6.405